Cancer Associated Manufacturers, Suppliers & Companies
-
Manufacturerbased in Golden, COLORADO (USA)
At Vitro Biopharma, our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market, and ultimately, to address well-established multi-billion-dollar ...
Vitro - Human Prostate Cancer Associated Fibroblasts: 1,000,000 Cells Per Vial
High passage capabilities. Expands in VitroPlusIII Low Serum, Complete Medium (Vitro Biopharma, Cat. No. PC00B1–optimized for high growth rates, reduced doubling times, healthy cells, and stability). Able to grow in low oxygen (1% - 5% O2). ...
CONTACT SUPPLIER -
Service providerbased in Astoria, NEW YORK (USA)
We develop immune system modulators that activate and direct the most powerful immune cells in the body for targeted responses to disease. Our underpinning science originates from two of New Zealand’s leading research institutes, the Ferrier ...
Avalia - Treatment Therapy for HPV-associated Cancers
Avalia’s patented chemical design lends itself well to the treatment of HPV-associated cancers. Certain strains of HPV are responsible for the onset of cervical cancer, many anogenital ...
CONTACT SUPPLIER -
Manufacturerbased in Virum, DENMARK
Immudex was created in 2009 when it spun off from the diagnostic company Dako, now Agilent. Since then, Immudex has grown in numbers, employees, patents, product lines, partnerships, and customers served. Research, development, and commercial ...
-
Manufacturerbased in Baldham, GERMANY
ORYX’ development strategy bridges the gap between academic research and the pharmaceutical industry for new cancer therapies. Today, the company is developing three clinical cancer immunotherapy projects in indications with high unmet medical need. ...
VicOryx - Model p16 - Therapeutic Vaccine
The human cyclin-dependent kinase inhibitor p16INK4a is a tumor antigen expressed in various cancers, including lung and breast cancer. In normal cells, p16INK4a is rarely expressed and leads to immediate ...
CONTACT SUPPLIER -
Technologybased in Cambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
-
Manufacturerbased in Pearl River, NEW YORK (USA)
Auro Vaccines LLC is a clinical-stage vaccine development company pioneering a major evolutionary step in the design and development of preventive and therapeutic vaccines for infectious diseases. Our novel approach is based on a proprietary ...
-
Manufacturerbased in Sunnyvale, CALIFORNIA (USA)
Olympia Diagnostics is an In Vitro Diagnostics (IVD) company focusing on development and commercialization of the most advanced breakthrough products for cancer diagnosis and prognosis. We developed a proprietary biomarker discovery platform to ...
Olympia - Model PCa-Px - Prognostic Test Kit
A prognostic test kit quantitatively measures the expression levels of a panel of cancer recurrence-associated biomarkers in patient urine sample or biopsy tissue sample to predict cancer recurrence ...
CONTACT SUPPLIER -
Manufacturerbased in Holytown, UNITED KINGDOM
We are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is to ...
Model TCB006 - B7-H4 CAR-T
cancer per year in the US. It is also implicated in cancers associated with infection by Epstein-Barr Virus (EBV). Previous efforts to target B7-H4 expression have been limited by off-tumor ...
CONTACT SUPPLIER -
Technologybased in Menlo Park, CALIFORNIA (USA)
Ionpath, Inc., is a pioneer in high-definition spatial proteomics, revolutionizing tissue imaging and analysis to accelerate medical discovery and improve human health. Ionpath’s MIBI (multiplexed ion beam imaging) platform breaks through the ...
Ionpath - Model 164Dy - a-SMA [D4K9N] Antibody
Background:α-smooth muscle actin (α-SMA, ACTA2) is one of six actin isoforms found in vertebrates. α-SMA is expressed in a variety of tissues and is used as a marker of vascular smooth muscle, myofibroblasts, and ...
CONTACT SUPPLIER -
Manufacturerbased in Morrisville, NORTH CAROLINA (USA)
NightHawk Biosciences is a commercial stage company with a fully integrated ecosystem focused on accelerating the discovery and development of novel medical countermeasures to defend against emerging biothreats. ...
Heat Biologics - Model HS-110 - Biologic Program
(viagenpumatucel-L) is an allogeneic “off-the-shelf” cellular vaccine derived from a lung adenocarcinoma cancer cell line and genetically modified to secrete a wide range of ...
CONTACT SUPPLIER -
Manufacturerbased in Seoul, SOUTH KOREA
NGS industries are rapidly evolving and our customers are in greater need of technical support in various research fields and markets. Just like a chameleon utilizing its colored pigments and crystals to adapt to its surroundings, we proactively ...
Celemics OncoRisk - Panel
Celemics’ Oncorisk Panel is specifically designed to analyze hereditary cancer associated genes. The OncoRisk Panel targets 31 well-known oncogenes, leading to a reduction of totalsequencing cost compared to ...
CONTACT SUPPLIER -
Manufacturerbased in Chicago, ILLINOIS (USA)
Tempus is making precision medicine a reality through the power and promise of data and artificial intelligence. With the world’s largest library of clinical and molecular data, and an operating system to make that data accessible and useful, we ...
Model Tempus xG - Targeted Panels of 88 (xG+) & 52 (xG) genes
Providing risk-assessment for hereditary cancer syndromes for patients and their families. xG+ (extended hereditary cancers): Covers genes associated with multiple hereditary cancer ...
CONTACT SUPPLIER -
Manufacturerbased in Dos Hermanas (Sevilla), SPAIN
Vaxdyn was founded in 2011 as a spin-off established by researchers of the Institute of Biomedicine of Seville, a center of the Andalusian Public Health System and the University of Seville linked to the University Hospital Virgen del Rocío of ...
-
Technologybased in Silicon Valley, CALIFORNIA (USA)
Da Zen Theranostics, Inc. (Da Zen) has developed revolutionary therapies for cancer detection, imaging, and treatment in order to prolong survival and improve quality of life for patients with cancer. The innovative research at Da Zen has led to the ...
-
Technologybased in Vancouver, BRITISH COLUMBIA (CANADA)
Canexia Health (formerly Contextual Genomics) makes high-quality cancer genomic information accessible and affordable with our clinically-validated assays, informatics, and support. Our genomics-based oncology solutions are designed to advance ...
Find It - Detect Mutations Treatment
mutations, and mutations with prognostic and diagnostic implications for care. Find It helps oncologists to tailor treatments based on the genomic mutations in their patients’ tumors for more personalized cancer ...
CONTACT SUPPLIER -
Manufacturerbased in Irvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
ConfirmMDx - Actionable Molecular Diagnostic System for Prostate Cancer
; otherwise cancer-free men from undergoing unnecessary repeat biopsies and screening procedures, helping to reduce complications, patient anxiety, and excessive healthcare expenses associated with these procedures. ...
CONTACT SUPPLIER -
Manufacturerbased in Meyzieu, FRANCE
CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in ...
-
Manufacturerbased in Palo Alto, CALIFORNIA (USA)
Immune-Onc is a clinical-stage company developing a novel class of myeloid checkpoint inhibitors. We believe myeloid checkpoints are the next frontier of immunotherapy for cancer. In collaboration with scientists, our research team is among the ...
Immune-Onc - Model IO-108 - (Anti-LILRB2) Mechanisms of Action Program
Immune-Onc is evaluating IO-108, an antagonist antibody targeting the myeloid checkpoint, LILRB2 (also known as ILT4). The U.S. FDA has cleared the IND application for IO-108 as a potential therapy for solid tumors. The company expects to begin ...
CONTACT SUPPLIER -
Technologybased in Pasadena, CALIFORNIA (USA)
LIXTE is a drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead clinical compound. LB-100 has potential widespread use as an anti-cancer agent when used alone and in ...
-
Manufacturerbased in Dulles, VIRGINIA (USA)
We are dedicated to improving patient outcomes by developing, supplying and delivering molecular diagnostics and therapeutics (theranostics). The early vision for molecular imaging was to revolutionize clinical diagnostics and therapeutics to better ...
Clinical Development Services
Staying true to our vision to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics, SOFIE has acquired global rights for the diagnostic and companion diagnostic use of the FAPI family of compounds from ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you